Sign Up
OverviewAPI
Immunis.AI's blood-based immune profiling study for prostate cancer aims to improve risk stratification, offering a non-invasive alternative to tissue biopsies. The study yielded promising results, potentially enhancing patient outcomes. Additionally, the global monkeypox diagnostics market sees a surge in demand due to the spread of the disease beyond African regions.

Ask a question